FDA Has Approved A New Medication Treatment For Migraines In Adults

Updated Feb 6, 2025 | 05:09 PM IST

SummaryMany people use the terms ‘migraine’ and ‘headache’ interchangeably. This leads many people to believe that migraines are not as serious as people make them out to be, and that cannot be more wrong, migraines have a major effect on a person’s lifestyle and the new approved medication may prove to be a great relief!
(Credit-Canva)

(Credit-Canva)

Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

End of Article

Measles Outbreak In Bangladesh Kills 98 Children: Report

Updated Apr 6, 2026 | 06:56 PM IST

SummaryAccording to the latest data from the country’s Ministry of Health, the number of children aged six months to five years old with suspected measles symptoms has soared to 6,476. ​The outbreak has prompted the government to launch an emergency vaccination drive in 18 high-risk districts.
Measles Outbreak in Bangladesh Kills 98 Children: Report

Credit: Canva

The vaccine-preventable measles, a deadly infectious disease, has claimed the lives of 98 children in Bangladesh, in the country’s one of the worst outbreaks, media reports said.

According to the latest data from the country’s Ministry of Health, the number of children aged six months to five years old with suspected measles symptoms has soared to 6,476, AFP News Agency reported

“Compared with past years, the number of affected children is higher, and the death toll is higher too,” Halimur Rashid, director at Communicable Disease Control, was quoted as saying.

The largest number of suspected cases on record was in 2005 at 25,934, according to World Health Organization (WHO) data. That number had significantly declined in succeeding years until this year.

Measles Outbreak: Emergency Vaccination Drive

Official data show that in 2026, more than 2,300 children were admitted to the hospital with suspected measles.

The outbreak has also prompted the government to roll out a vaccination program for younger children in a bid to halt the outbreak. The emergency vaccination drive will be launched in 18 high-risk districts, and will also be expanded from May 3 to cover the entire country.

Directorate General of Health Services (DGHS) said 10 of the total 94 measles-related deaths occurred in 24 hours ending at 8 am Sunday, even as the number of suspected measles cases detected grew to 5,792 during the 19 days, 974 of them since Saturday.

"The highly infectious disease has seen a sharp rise this year, particularly since March," a DGHS statement said, attributing the phenomenon to the vaccination gap last year, PTI reported.

The officials noted that the disease is spreading rapidly and has affected 56 out of 64 administrative districts.

Health Minister Sardar Shakhawat Hossain Bakul said the emergency vaccination drive would cover the "worst affected areas" before being expanded throughout Bangladesh.

What Is Measles?

Measles is a highly contagious virus that spreads through direct contact or through the air when an infected person coughs or sneezes.

Symptoms typically appear seven to 14 days after exposure and may include:

  • high fever,
  • cough,
  • runny nose,
  • red eyes,
  • rashes across the body.

Measles And Vaccination

Measles is a vaccine-preventable disease that can cause devastating complications, including blindness, pneumonia, encephalitis, and long-term immune dysfunction.

The reports of deaths from Bangladesh indicate the presence of a significant 'immunity gap,” allowing the virus to take hold.

How Does Measles Spread

Measles is a highly contagious viral disease that spreads rapidly through respiratory droplets when an infected person coughs or sneezes.

Crowded living conditions, poor ventilation, and low immunity levels increase the risk of transmission.

In addition to incomplete or missed vaccination, lack of awareness, and malnutrition (especially vitamin A deficiency) contribute to outbreaks.

How To Stay Safe

To safeguard against measles, individuals should:

  • Ensure timely vaccination, especially for children.
  • Maintaining good hygiene, such as frequent handwashing and covering the mouth while coughing or sneezing
  • Avoiding close contact with infected individuals
  • Eensure proper nutrition to boost immunity
  • Public awareness and community health programs also play a crucial role.

End of Article

Chandigarh Doctor Alleges Hospital Forcibly Keeping All Patients In ICU

Updated Apr 6, 2026 | 01:35 PM IST

SummaryIn January 2024, India launched guidelines for hospitals on ICU admissions and directed that hospitals cannot admit critically ill patients to the ICU without the consent of the patient and family. According to the latest guidelines, patients who are critically ill should not be admitted to an ICU if they do not give their consent.
Chandigarh Doctor Alleges Hospital Forcibly Keeping All Patients In ICU

Credit: Canva/Instagram

A young Internal Medicine doctor from Chandigarh has highlighted shocking malpractices followed by a well-known private hospital.

In a widely shared video posted on social media platform Instagram, Dr Prabhleen Kaur alleged that all patients arriving at the hospital in the city are being forcibly kept in Intensive Care Units (ICUs) even when it is not required.

The doctor had joined the hospital, as it was paying well and was near her clinic. However, seeing the blatant scam, she resigned in just one day.

Also Read: Scientists Link Vaping to 2 Types of Cancer; DNA-Damaging Chemicals to Blame

“I joined a very reputed hospital. I thought I would work there in the mornings and run OPD at my own clinic in the evenings. They were paying really well, no doubt about that,” the doctor said in the video.

The doctor alleged that the hospital “just needed a physician for the show”, while the entire handling of patients was being done by the owner, a gynecologist.

“But on my very first day, I realised that they only needed a physician in name. The hospital owner, who was a gynaecologist and not a physician, was managing all the patients herself. That means she would decide every patient should be admitted, and she would also decide that every admitted patient should be kept in the ICU – and kept there for as many days as possible,” Kaur said.

She further claimed that the goal at the said hospital was to make the patients remain admitted in the ICU for as long as possible. Kaur added she was deeply disturbed seeing this and refused to be part of a system that “harms patients for money.”

“It would have been my name, but their wrongdoing. So I resigned, because I cannot allow someone to use me as a front for unethical practices,” she said.

The doctor did not mention the name of the hospital. And HealthandMe could not independently verify the details and the authenticity of the post.

However, the incident reignites concerns over accountability, patient safety, and standards of care in the country.

The video went viral and the netizens found it concerning, and some also pointed out that such issues are common with many hospitals across the country.

"Unfortunately, most doctors are doing this unethical practice these days,” a user said.

“No surprise— the moment you enter a hospital, the first question is about insurance coverage. Feels like treatment comes second and billing comes first,” added another.

Some also lauded the doctor for resigning and sounding the alarm.

“Salute to your integrity. Rest of the Indians are just after making money,” said a user, while another noted: “Respect to this doctor for choosing her conscience over money".

Also read: NASA’s Artemis II Mission To Test Human Health in Deep Space

Other Such Incidents

This is not the first such incident of hospital malpractice in the country.

Days earlier, a doctor from Assam called out private hospitals for overcharging patients with inflated medicine prices and unnecessary lab tests.

Dr Priyam Bordoloi said that corporate hospital chains rely on “predatory” practices and become a “financial sinkhole” for patients.

Earlier in January this year, a viral video with allegations of gross medical negligence and institutional apathy at Dhubri Medical College and Hospital (DMCH) sparked public outrage.

The video showed a family accusing hospital staff of failing to provide basic care, delaying critical dialysis treatment, and obstructing an emergency transfer.

The incident involved a 74-year-old Fulchand Chowdhury, whose condition reportedly worsened due to lapses in ICU monitoring, sanitation, and patient safety.

The family claimed they were forced to care for him themselves and faced resistance when seeking transfer to a private facility.

Also read: Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer Treatment

Who Should Be Kept In The ICU?

In January 2024, India launched guidelines for hospitals on ICU admissions and directed that hospitals cannot admit critically ill patients to the ICU without the consent of the patient and family.

According to the latest guidelines, patients who are critically ill should not be admitted to an ICU if they do not give their consent.

"Critically ill patients should not be admitted to the ICU; if the patient or next-of-kin informed refusal to be admitted in ICU."

End of Article

NASA’s Artemis II Mission To Test Human Health in Deep Space

Updated Apr 5, 2026 | 04:00 AM IST

SummaryDuring the 10-day journey, the four astronauts will conduct several science experiments that will lay the foundation for safe and efficient human exploration of the Moon and Mars.
NASA’s Artemis II Mission To Test Human Health in Deep Space

Credit: NASA

Nearly 60 years after humanity first set foot on the Moon, NASA has launched its historic Artemis II mission, marking the first crewed journey around the lunar surface.

The nearly 10-day flight was launched successfully on April 1 from the Kennedy Space Center (KSC) in Florida at 6:24 p.m. EDT.

Four astronauts were launched to the surface of the Moon aboard Orion, which lifted off atop NASA's Space Launch System.

The Orion spacecraft flight carries NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, along with Canadian Space Agency astronaut Jeremy Hansen.

The crew aims to loop around the moon and return to Earth on a free-return trajectory, reaching roughly 4,700 miles (7,560 kilometers) beyond the moon's far side — farther than Apollo 8's historic lunar flyby and the most distant journey ever attempted by humans.

During the 10-day journey, the four astronauts will also perform several science experiments, along with scientists on Earth, to facilitate science investigations to inform future human spaceflight missions.

NASA stated that the Artemis II science operations will lay the foundation for safe and efficient human exploration of the Moon and Mars.

Health Research in Space

The astronauts will conduct five research projects while in orbit. These include:

  • Artemis Research for Crew Health and Readiness (ARCHeR)
It will monitor participating astronauts' well-being, activity, and sleep patterns to learn more about human health and performance in deep space.

The study will evaluate how crew members perform individually and as a team throughout the mission, including how easily they can move around within the confined space of their Orion spacecraft.

  • A Virtual Astronaut Tissue Analog Response (AVATAR)
An investigation will use organ-on-a-chip devices to study the effects of increased radiation and microgravity on crew health. The organ-on-a-chip devices containing astronaut cells will also study how deep space travel affects humans at a cellular level.

  • The Immune Biomarkers
This study will explore how the immune system reacts to spaceflight.

Scientists will analyze blood and saliva samples from Artemis II crew members to see how deep space changes the immune system.

  • Artemis II Standard Measures
Astronauts will collect a standardized set of measurements spanning multiple physiological systems to provide a comprehensive snapshot of how spaceflight affects the human body.

Crews are supplying a consistent set of health information to a data bank so that future researchers can learn more about astronaut health.

  • Radiation Studies
Radiation sensors are placed inside the Orion capsule cells, which will collect additional information about radiation shielding functionality.

Equipment will monitor radiation levels inside and outside the Orion capsule to help characterize the deep space environment.

NASA’s Artemis II Mission To Test Human Health in Deep Space

“The findings are expected to provide vital insights for future missions to destinations beyond low Earth orbit, including Mars,” said Laurie Abadie, an aerospace engineer for the program at NASA’s Johnson Space Center in Houston.

“The lessons we learn from this crew will help us to more safely accomplish deep space missions and research,” she said.

Steven Platts, chief scientist for human research at NASA Johnson, explained the mission will need to protect against challenges, including exposure to higher radiation levels than on the International Space Station, since the crew will be farther from Earth.

“Together, these studies will allow scientists to better understand how the immune system performs in deep space, teach us more about astronauts’ overall well-being ahead of a Mars mission, and help scientists develop ways to ensure the health and success of crew members,” he said.

End of Article